New York S 4501: Relates to the definition of practice of pharmacy

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S04501 Summary:

BILL NOS04501 

&nbsp

SAME ASSAME AS A02534

&nbsp

SPONSORRIVERA

&nbsp

COSPNSRADDABBO, BORRELLO, CHAN, COONEY, GALLIVAN, MAY, ROLISON, SALAZAR, SEPULVEDA, SKOUFIS, WEBB, WEBER,
 WEIK

&nbsp

MLTSPNSR

&nbsp

Amd §6801, Ed L

&nbsp

Provides for the initiation of treatment for COVID-19, influenza, and pharyngitis resulting from a Group A streptococcal infection by a licensed pharmacist in certain circumstances.

Go to top S04501 Actions:

BILL NOS04501 

&nbsp

02/06/2025REFERRED TO HIGHER EDUCATION

01/07/2026REFERRED TO HIGHER EDUCATION

Go to topS04501 Committee&nbspVotes:

Go to topS04501 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS04501 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 4501

 2025-2026 Regular Sessions

 IN SENATE

 February 6, 2025
 ___________

 Introduced by Sens. RIVERA, BORRELLO, MAY, ROLISON, SALAZAR, SEPULVEDA,
 WEBB, WEIK -- read twice and ordered printed, and when printed to be
 committed to the Committee on Higher Education

 AN ACT to amend the education law, in relation to the definition of
 practice of pharmacy; and providing for the repeal of such provisions
 upon expiration thereof

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Section 6801 of the education law is amended by adding a
 2 new subdivision 7-a to read as follows:
 3 7-a. (a) A licensed pharmacist may initiate treatment for COVID-19,
 4 influenza, and pharyngitis resulting from a Group A streptococcal
 5 infection upon a positive test result conducted pursuant to subdivision
 6 seven of this section. Such treatment shall be provided pursuant to a
 7 statewide protocol developed by the department of health. Such protocol
 8 shall address issues including but not limited to patient safety, record
 9 keeping, referral for treatment and continuity of care, case reporting
 10 to the patient's primary care or other health care providers. The proto-
 11 col shall also include procedures for appropriate referrals for any
 12 patient that requires additional treatment or experiences an adverse
 13 reaction to the treatment authorized pursuant to this subdivision.
 14 (b) A pharmacist initiating treatment under this protocol shall at a
 15 minimum: (i) inquire of each patient whether the patient has a primary
 16 care provider or other health care provider that the patient regularly
 17 sees; and (ii) maintain and regularly update a list of local primary
 18 care providers including those located in the applicable zip code area
 19 and adjacent zip code areas of the pharmacy. This list shall be provided
 20 to each patient who indicates that the patient does not have a primary
 21 care provider.
 22 (c) The department of health shall produce, maintain, and periodically
 23 update a list of primary care providers on its website, in searchable

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD03393-01-5

 S. 4501 2

 1 form that shall include relevant zip codes of the providers. The list
 2 developed by the department of health shall identify preferred providers
 3 who have achieved recognition as a patient centered medical home (PCMH)
 4 or other similar designation and a description of what such designation
 5 means. The list shall include federally qualified health centers and
 6 other providers who serve Medicaid, low-income and uninsured patients,
 7 and people with disabilities and shall identify cultural and linguistic
 8 capabilities when available.
 9 (d) A pharmacist shall retain a record of the test result and treat-
 10 ment as part of the patient record and shall at a minimum provide a
 11 report of the test result and treatment to the patient's designated
 12 physician, physician's assistant or nurse practitioner, unless otherwise
 13 directed by the patient.
 14 § 2. This act shall take effect immediately and shall expire and be
 15 deemed repealed April 1, 2028.

Go to top 

• 

 Sitemap 

 Request Information 

 Directions and Maps